Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696397 · ClinicalTrials.gov registry record
Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology
A clinical trial, sponsored by Wake Forest University.
- Completed
- Registry status
- 31
- Enrollment target
NCT00696397: Completed study, sponsored by Wake Forest University.
NCT00696397 is a clinical trial that has completed, run by Wake Forest University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00696397 has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The purpose of this research is to study the sleep patterns of people with moderate to severe atopic dermatitis and how itching affects those patterns. This study will also measure your body's activity during sleep using non-invasive tests described below.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-12 |
What the finished NCT00696397 record still lists
NCT00696397 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00696397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00696397 about?
NCT00696397 is a clinical study titled "Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology". The purpose of this research is to study the sleep patterns of people with moderate to severe atopic dermatitis and how itching affects those patterns. This study will also measure your body's activity during sleep using non-invasive tests described below.
What is the current status of trial NCT00696397?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2006-03. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00696397?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia